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Background: HIV-1 DNA is found both integrated in the host chromosome and unintegrated in various forms:
linear (DNAL) or circular (1-LTRc, 2-LTRc or products of auto-integration). Here, based on pre-established strategies,
we extended and characterized in terms of sensitivity two methodologies for quantifying 1-LTRc and DNAL,
respectively, the latter being able to discriminate between unprocessed or 3′-processed DNA.
Results: Quantifying different types of viral DNA genome individually provides new information about the
dynamics of all viral DNA forms and their interplay. For DNAL, we found that the 3′-processing reaction was efficient
during the early stage of the replication cycle. Moreover, strand-transfer inhibitors (Dolutegravir, Elvitegravir, Raltegravir)
affected 3′-processing differently. The comparisons of 2-LTRc accumulation mediated by either strand-transfer
inhibitors or catalytic mutation of integrase indicate that 3′-processing efficiency did not influence the total
2-LTRc accumulation although the nature of the LTR-LTR junction was qualitatively affected. Finally, a significant
proportion of 1-LTRc was generated concomitantly with reverse transcription, although most of the 1-LTRc were
produced in the nucleus.
Conclusions: We describe the fate of viral DNA forms during HIV-1 infection. Our study reveals the interplay between
various forms of the viral DNA genome, the distribution of which can be affected by mutations and by inhibitors of
HIV-1 viral proteins. In the latter case, the quantification of 3′-processed DNA in infected cells can be informative about
the mechanisms of future integrase inhibitors directly in the cell context.
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After HIV-1 particles enter their target cells, reverse
transcriptase converts HIV-1 viral RNA into a double-
stranded linear DNA (DNAL). The resulting DNAL moves
into the nucleus as a component of the pre-integration
complex (PIC) and then integrates into the host cell
genome [1]. Integration of DNAL is essential for a pro-
ductive infection [2,3]. This process requires the integrase
activity for the 3′-processing reaction at both LTR (Long
Terminal Repeat) extremities of the blunt (or unpro-
cessed) DNA, named uDNAL, leading to 3′-processed
linear DNA (pDNAL) [4]. This reaction involves the re-
moval of a dinucleotide after the canonical 5′-CA found
in all retroviruses. The integrase-mediated integration of
pDNAL into the host cell genome can be efficiently in-
hibited by integrase strand-transfer inhibitors (INSTIs)* Correspondence: delelis@lbpa.ens-cachan.fr
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reproduction in any medium, provided the or[5], including Raltegravir (RAL), Dolutegravir (DTG) and
Elvitegravir (EVG); this inhibition is similar to that associ-
ated with inactivation of the catalytic triad of integrase
(for example due to D116N/A mutation [6,7]). It is
important to note that the INSTI compounds, unlike cata-
lytic mutants, are not supposed to influence the 3′-pro-
cessing reaction and inhibit the strand transfer reaction of
the integration process only [8]. It is intriguing to note
that the context of catalytic mutant or INSTI treatment
lead to similar 2-LTRc accumulation despite differentially
affecting the 3′-processing step [9,10]. One possible ex-
planation is that although INSTI are specific strand trans-
fer inhibitors in vitro, they may affect the 3′-processing
reaction in the cell context. Alternatively, the formation of
2-LTRc could be compatible with both types of viral DNA
ends, processed or unprocessed leading to both 2-LTRc
encompassing a perfect palindromic junction (resulting
from ligation of blunt extremities) and others with an im-
perfect palindromic junction (most likely originating fromtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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solved because quantitative and sensitive data about the
fate of linear HIV-1 DNA, more particularly for sep-
arately quantifying the two principal forms of linear
DNA (pDNAL and uDNAL), are not well-established.
In addition to DNAL (=pDNAL + uDNAL), uninte-
grated forms of HIV-1 DNA include DNA circles which
harbor one or two LTR (1-LTRc and 2-LTRc, respec-
tively); 1-LTRc is formed by circularization of DNAL by
homologous recombination and 2-LTRc by the Non-
Homologous End Joining (NHEJ) pathway [12-14].
Other circular forms, resulting from auto-integration,
could also be detected using PCR assays [15]. For in-
stance, in the context of 2-LTRc, auto-integration
events lead to 2-LTRc harboring imperfect palindro-
mic junction in contrast to 2-LTRc originating from
NHEJ [11]. Although 2-LTRc are considered to be dead-
end molecules, 1-LTRc may sustain viral gene expres-
sion [13,16].
To date, few quantitative data about the intracel-
lular localization of HIV-1 DNA species are available.
Moreover, the relative abundance of the different viral
DNA forms is dynamic and is dependent of viral con-
ditions of infection. The intracellular localization of
viral genomes has been determined by Southern blot-
ting experiments [17]. However, this approach suffers
from a lack of detection sensitivity and the distribu-
tion of viral forms can be assessed only qualitatively.
Although real-time PCR-based protocols have been
developed for accurately quantifying the integrated, 2-
LTRc and total viral DNA forms [18,19], no method
for accurate quantification of 1-LTRc is available [20].
Concerning DNAL, based on previous established
strategy [21], we explored the optimal conditions for
reliable quantification and further characterized the
quantification of pDNAL and uDNAL, and compared
the sensitivity of this approach to that of Southern
blotting.
We report original information related to the dynam-
ics of all viral DNA genomes, and the efficiency and
localization of the 3′-processing reaction. We also de-
scribed the action of the anti-integrase compounds.
Mainly, we found that 3′-processing is an efficient
process (80% of linear DNA is processed) occurring in
cytoplasm at early stage of the replication cycle, con-
comitant with or soon after reverse transcription. Fur-
thermore, we show that INSTIs at sub-micromolar
concentrations that fully prevent integration do not in-
hibit the 3′-processing reaction in the context of viral
infection. Regarding circular forms, we observed that
1-LTRc are mainly formed in the nucleus but, unlike
2-LTRc which are exclusively generated in the nucleus, a
small but significant proportion (10%) of 1-LTRc are
formed in the cytoplasm.Results
To extend the quantitative analysis to other HIV-1 DNA
forms, we addressed two quantitative protocols based on
real-time PCR for quantifying linear viral DNA and
1-LTRc. Regarding linear viral DNA, we used a linker-
mediated PCR method based on a qualitative approach
described by Pierson and colleagues [22] (see Methods).
This method involves using the 11TAb linker to detect
total HIV-1 linear DNA (i.e. the processed, pDNAL, and
unprocessed, uDNAL) and the 11b linker to detect
uDNAL only (Figure 1). The quantification of both linear
DNA forms was reliable as attested by the good per-
formance in terms of efficiency and sensitivity (90% effi-
ciency over a 7-log range and a sensitivity of 100 DNA
copies per 106 cells) (Figure 1). This method was more
sensitive than Southern blotting, for which the limit of
detection was 105 copies per 106 cells (Additional file 1:
Figure S1A). Thus, this method is suitable for quantita-
tive analysis of the 3′-processing reaction in the viro-
logical context. It is important to note that, following
infection, the overhanging dinucleotide of the processed
HIV-1 DNA is 5′-AC (for the LTR5′ or LTR3′) and not
the 5′-TA found in pDNAL (resulting from the NdeI/
AatII digestion of pLIN-HIV-NdeI). Thus, in order to
extend the quantification procedure for DNAL in the
virological context, the linker 11GTb (with a TG-5′
overhanging; Additional file 1: Table S1A) was used ra-
ther than 11TAb in further experiments described below
(the linker used for uDNAL quantification was still 11b).
The efficiency of the method using the linker 11GTb
was verified (Additional file 1: Figure S1B).
Southern blotting analyses indicate that the amounts
of 1-LTRc during infection are not negligible: 1-LTRc
are more abundant than 2-LTRc and are present in
similar amount compared to DNAL [23]. Thus, their
accurate quantification is required to understand the re-
lationships between the different viral DNA forms. Des-
pite previous efforts to develop PCR-based methods for
quantifying 1-LTRc [24,25], it has been reported that
these methods are inaccurate [20]. Indeed, primers hy-
bridizing in the env and gag genes could lead to am-
plification of the LTR-LTR region in 2-LTRc and
amplification of DNAL via LTR recombination [20] (see
also Figure 2A). We therefore optimized an improved
quantitative PCR protocol for 1-LTRc by addressing
as a first criterion the detection of undesirable above-
mentioned amplification products. We found that the
elongation time was the crucial parameter to ensure spe-
cific amplification of 1-LTRc. Among the different tested
conditions (modulation of the elongation time of the
PCR), we found that 25 s was optimal (Additional file 1:
Figure S2). Using p1-LTR for establishing a standard
curve, we found that our protocol gave good amplifica-
tion (92.5-100%) and provided sensitive detection (200
Figure 1 Quantification of linear viral DNA. (A) Plasmids pLIN-HIV-ScaI and pLIN-HIV-NdeI are depicted. These plasmids were used as controls
for the reaction specificity. DNAs mimicking uDNAL and pDNAL were obtained by ScaI/AatII and NdeI/AatII digestion of pLIN-HIV-ScaI and pLIN-
HIV-NdeI, respectively. (B) Amplification of serial dilutions of the pLIN-HIV-ScaI plasmid. Parameters of the PCR (slope of the regression curve and
intercept) using primers 25 t and MS2 are shown in the figure. (C) Amplifications resulting from the LM-PCR protocol, using the two linkers 11b
or 11TAb in combination with DNA mimicking uDNAL or pDNAL. After ligation, all possible combinations were subjected to the LM-PCR protocol.
The input was defined as the initial amount, determined by quantitative PCR. The output is the value obtained by quantification with the LM-PCR
protocol. Efficiency is defined as the output:input ratio. The standard curves used for pDNAL and uDNAL quantifications in infected cells were
obtained using 11TAb and 11b linkers, respectively (using serial dilutions of fragments obtained by NdeI/AatII and ScaI/AatII digestions of
pLIN-HIV-NdeI and pLIN-HIV-ScaI, respectively). Right panel: PCR products from the various amplifications were loaded on agarose gel; M:
Molecular weight marker.
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dressed the question of detection specificity and the
influence of 2-LTRc content on the 1-LTRc quantifica-
tion during infection by using Nalm-6 (ligase-4+) and
Nalm-114 (ligase-4-) cells infected with HIV-1 Δenv vi-
ruses, either WT or D116N (a catalytic mutant of in-
tegrase [7]) [26]. It was previously described by Southern
blot analysis that ligase-4 is involved in the formation of
2-LTRc only (not 1-LTRc) and that the D116N mutation
leads to a substantial increase in the 2-LTRc content in
the ligase-4+ context due to integration defect (to a
much less extent the 1-LTRc content) [27]. Quantifica-
tions of total viral DNA as well as each circular viral
DNA form (1-LTRc or 2-LTRc) were performed at dif-
ferent times post-infection (p.i.) (Figure 2D). Our results
confirmed the strong inhibition (by a 40-fold factor) of
2-LTRc formation for both WT and D116N in Nalm-114
compared to Nalm-6 [12]. The amounts of 1-LTRc were
similar in both cell lines infected by WT or D116N. This
result confirms that the ligase 4 is not involved in the
formation of 1-LTRc, consistent with the qualitative re-
sults reported by Li and colleagues [28]. Importantly, the
amount of 1-LTRc was found to be similar regardless
of the amount of 2-LTRc accumulated (compare in
Figure 2D Nalm-6 and Nalm-114 infected by D116N).
This confirms that our quantitative approach allows anaccurate quantification of 1-LTRc in the cellular context
without any bias due to the presence of 2-LTRc.
Based on (i) previously validated PCR-based protocols
for quantification of total viral DNA, 2-LTRc and inte-
grated viral DNA and (ii) the improvement described
above for quantification of 1-LTRc, uDNAL and pDNAL,
we established the time course of these HIV-1 genomes
during infection.
Exhaustive time course study of viral DNA forms during
infection
We used MT4 cells infected with Δenv viruses (WT+/-
RAL or D116N) as a model system to study the kinetics
of viral DNA forms (integrated viral DNA, 1-LTRc, 2-
LTRc and DNAL) during a single-round of viral replica-
tion [26]. Viral DNA was analyzed at different times p.i..
In the WT context, total HIV-1 DNA level peaked 8 h
p.i. and then decreased steeply until 32 h p.i. (Figure 3A)
to match the integrated HIV-1 DNA level (Figure 3B) as
already reported [18]. Integration inhibition by RAL or
due to the D116N mutation did not influence reverse
transcription as total viral DNA synthesis was similar to
the WT condition (Figures 3A and B). Under integration
inhibition conditions, 2-LTRc accumulated to reach a
maximum at 24 h-32 h p.i. whereas the amount of 2-
LTRc in the WT context remained low (Figure 3C), as
Figure 2 Quantification of 1-LTRc. (A) Possible amplifications from the various substrates found in infected cells with primers used for 1-LTRc
quantification. 1: 1-LTRc; 2: 2-LTRc and 3: linear viral DNA. (B) Plasmids (1: p1-LTR and 2: p2-LTR) used as controls. Linear DNA (3) was obtained by
ScaI digestion of p2-LTR. (C) Amplification of serial dilutions of p1-LTR using the protocol for 1-LTRc amplification. Amplification of known
amounts of p1-LTR (1), p2-LTR (2) and linear DNA (3) using the protocol for 1-LTRc quantification. The results are reported in the table, for an
elongation time of 25 s. Input: initial amount of target. Output: amount measured with the 1-LTRc protocol. %Amplification calculation is based
on the output:input ratio. The plot shows the amplification results with known amounts of p1-LTR. The PCR products obtained with the various
substrates were loaded onto an agarose gel (shown below the table). M: Molecular weight marker. (D) 1-LTRc quantification is not influenced by
the presence of 2-LTRc. Nalm6 and Nalm114 cells were infected with VSV-G-pseudotyped NLENG1-ES-IRES WT (left panel) or NLENG1-ES-IRES
D116N (right panel). At different times post-infection, the percentages of 2-LTRc and 1-LTRc were determined in Nalm6 (ligase-4+) (black
columns) and Nalm114 (ligase-4-) (white columns) cell lines. Each value corresponds to an average of five to six independent experiments and
confidence intervals analysis are shown for a p value <0.05.
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behavior in the different conditions reveals two interest-
ing observations. The first one is related to 1-LTRc: In
the short time scale p.i. (until 5 h), significant 1-LTRc
amount was detected while, in the same time, no 2-
LTRc was detected. This result is intriguing because in
a longer time scale p.i. (after 5 h), 1-LTRc synthesis
followed 2-LTRc synthesis. The reason for such an ap-
parent discrepancy will be further discussed (see next
section). The second one concerns the similar accumula-
tion of 2-LTRc in both conditions of IN inhibition: pres-
ence of RAL or D116N mutation. This observation is
intriguing in first approximation because it is known
that RAL and D116N differentially affect 3′-processing.Two hypotheses may explain such observations: (i) Ei-
ther RAL behaves differentially in the virological context.
(ii) The accumulated 2-LTRc are qualitatively different.
Until now, 2-LTRc accumulation was studied using
primers spanning the LTR-LTR junction, such that the
nature of the LTR-LTR junction (representing global 2-
LTRc) cannot be investigated. Recently, De Iaco et al.
used oligonucleotides hybridizing at the palindromic
junction, and discriminated 2-LTRc harboring a perfect
palindromic sequence at the LTR-LTR junction (resulting
from ligation of unprocessed extremities) from those har-
boring a deletion or insertion (imperfect palindrome, for
instance formed by auto-integration) [11]. Using this set-
ting, we confirm that the accumulation of global 2-LTRc
Figure 3 Kinetics of total, circular, linear and integrated DNA forms during a single round of replication. MT4 cells were infected with the
VSV-G-pseudotyped NLENG1-ES-IRES WT (+/- RAL 500 nM) or NLENG1-ES-IRES D116N viruses. Each value corresponds to an average of five to six
independent experiments and confidence intervals analysis are shown for a p value <0.05. (A) Total viral DNA. (B) Integrated viral DNA. (C) 2-LTRc.
(D) Percentage of 2-LTRc (2-LTRc/Total viral DNAx100). (E) 1-LTRc. (F) Percentage of 1-LTRc (1-LTRc/Total viral DNA x 100). (G) Kinetics of total
linear viral DNA (uDNAL + pDNAL). WT: black squares; WT + 500 nM RAL: black diamonds; D116N: white circles. (H) Time course of linear viral DNA
as a percentage of total viral DNA during infection. WT: black columns; WT + 500nM RAL: grey columns; D116N: white columns.
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ment or by D116N mutation (Figure 4A). However, the
accumulation of 2-LTRc harboring a perfect palindromic
junction was similar, at about 40%, for WT and RAL
conditions, but much higher, about 80%, in the case
of D116N (Figure 4B). In conclusion, even though3′-processing influences the nature of the palindromic
junction, the global amount similarly increases when
integration is inhibited, regardless of the 3′-processing
status.
Yan et al. have shown that auto-integration occurs
during reverse transcription leading to circular forms
Figure 4 Characterization of the nature of the LTR-LTR junction. MT4 cells were infected with the VSV-G-pseudotyped NLENG1-ES-IRES WT
(+/- RAL 500 nM) or NLENG1-ES-IRES D116N viruses. Each value corresponds to an average of five to six independent experiments and confidence
intervals analysis are shown for a p value <0.05. (A) 2-LTRc as a percentage of total HIV-1 DNA 24 h post-infection (black column, global 2-LTRc
and grey column, 2-LTRc harboring a perfect LTR-LTR junction). The fold increase in the amount of 2-LTRc (between integration defective
conditions (WT + RAL and D116N) and the WT) is indicated at the top of the columns. (B) 2-LTRc harboring a perfect palindromic sequence as a
percentage of total 2-LTRc in each condition of infection (WT, WT + RAL and D116N). (C) Standard curves with p2-LTR using primers and probes
for quantification of 2-LTRc harboring a perfect LTR-LTR junction (left panel) and for quantification of total 2-LTRc (right panel).
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the D116N/A mutant. Indeed, RAL or the D116N/A
mutation abolish the auto-integration activity of inte-
grase [15]. Our data suggest that the nature of the palin-
dromic junction is influenced by 3′-processing but is
not directly related to auto-integration. Indeed, the accu-
mulation of 2-LTRc harboring an imperfect junction in
the presence of RAL raises the question related to the
relationship between these 2-LTRc forms and the auto-
integration events since RAL is supposed to inhibit
auto-integration. The mechanism behind the formation
of these 2-LTRc forms remains to be elucidated.
The observed decreasing phase for circular forms
corresponded to dilution due to cell division, in contrast
to that observed for integrated forms (Figure 3B). In-
deed, the absolute quantities of both 2-LTRc and
1-LTRc significantly decreased (Figures 3C and E) while
their representativeness (normalized by total viral DNA)
remained roughly constant (Figures 3D and Figure 3F,
respectively). In the case of integrated forms, both their
absolute quantity and their representativeness remained
constant. A third behavior was observed with linearDNA: The maximal amount of DNAL was obtained 8 h
p.i. coinciding with the maximal amount of total viral
DNA originating from reverse transcription (Figure 3G).
After 8 h p.i., the amount of DNAL decreased con-
tinuously. In contrast to that observed with viral DNA
circular forms, the representativeness of DNAL also de-
creased in all conditions of infections (WT+/- RAL and
D116N). This indicates that DNAL is less stable than
1-LTRc and 2-LTRc (Figure 3H) (for a detailed analysis
of pDNAL and uDNAL stabilities, see section related to
3′-processing quantification). Intriguingly, along the de-
creasing phase characterizing the WT infection, we
observed a reproducible rebound of DNAL synthesis oc-
curring between 32 and 48 h p.i., after a significant
decreasing phase occurring between 8 and 24 h p.i.. Ex-
periments are ongoing to explain this phenomenon.
Regarding the accumulation of circular DNA forms, it
is important to note that impairing integration (RAL
treatment or D116N infection) increased the accumula-
tion of 1-LTRc and to a greater extent the accumulation
of global 2-LTRc (compare Figures 3C and E). Accumu-
lations of both 2-LTRc and 1-LTRc were also reflected
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viral DNA), but again, with a much more greater relative
accumulation for 2-LTRc (10-fold) compared to 1-LTRc
(2-fold) (Figures 3D and F). Indeed, in the RAL or
D116N context, 2-LTRc reached 15-20% or 25-27% of
total viral DNA, respectively, compared to 2% in the
standard infection condition (Figure 3D), while 1-LTRc
reached 50-60% of total viral DNA compared to 30% in
the standard infection (Figure 3F). Moreover, our results
indicate that the relative representativeness of 1-LTRc
and 2-LTRc remained roughly constant from 32 h p.i.
showing that the two circular viral DNA forms are rela-
tively and equally stable.
Two origins for 1-LTRc formation
As mentioned above, 1-LTRc were detected earlier than
2-LTRc in a context where their respective represen-
tativeness were comparable (D116N or WT + RAL)
(Figure 3E). This prompted us to re-examine the ques-
tion of subcellular location for 1-LTRc formation. To
date, the origin of 1-LTRc formation remains unclear
leading to apparent contradiction in the literature. For
instance, Kilzer and colleagues reported that 1-LTRc for-
mation requires homologous recombination between the
two LTR of DNAL which occurs in the nucleus [12]. By
contrast, in an early study, Miller and colleagues pro-
posed that 1-LTRc formation involves the reverse tran-
scription step in the cytoplasm compartment [30]. We
conducted cell fractionation experiments with MT4 cells
24 h p.i. infected with D116N (when amount of 2-LTRc
is maximal; as 2-LTRc are formed exclusively in the nu-
cleus, nuclear import has occurred at this time point
[31]). ß-globin and mitochondrial genes quantifications
were used as controls for cell fractionation validation
(Figure 5A, right panel). Our results demonstrate that
2-LTRc were almost entirely detected in the nuclear
fraction (>99.5%) (Figure 5A, left panel). The 1-LTRc
amount was much more higher in the cytoplasmic frac-
tion compared to 2-LTRc. Indeed, in conditions where
the nuclear import is maximal, 1-LTRc formed in the
cytoplasm represent 10% of total 1-LTRc (compared
to <0.5% for 2-LTRc). This is consistent with the kinetics
of 1-LTRc formation where 1-LTRc makes up 10% of
total viral DNA as soon as 5 and 8 h p.i. (Figure 3E).
These observations are compatible with the hypothesis
of Miller and collaborators [30] that, at least, some of
the 1-LTRc are produced during the reverse transcrip-
tion step.
Peptides NLS-IN-Pen and SV40-NLS-Pen, previously
described to inhibit the PIC nuclear import by inhibiting
the Integrase-importinα interaction [32], were used to
assess whether 1-LTRc are only formed during the re-
verse transcription step independently of PIC transloca-
tion. The amount of 1-LTRc was then measured and thenuclear import inhibition efficiency was monitored by
quantification of 2-LTRc. HeLa cells, treated with either
of these peptides, were infected with a pNL4.3 virus in
the presence of RAL. In the absence of the peptides,
2-LTRc accumulated to 19.3% of total viral DNA 48 h
p.i.. Peptide treatments led to an inhibition of 2-LTRc
accumulation (5.22% and 2.24% for NLS-IN-Pen and
SV40-NLS-Pen, respectively) confirming nuclear import
inhibition (3.7 and 8.6 fold for NLS-IN-Pen and SV40-
NLS-Pen, respectively) (Figure 5B, left panel). Interes-
tingly, in these conditions, we observed a decrease in
1-LTRc formation but not to the same extent compared
to 2-LTRc inhibition (1.8 and 2.5 fold for NLS-IN-
Pen and SV40-NLS-Pen, respectively) (Figure 5B, right
panel). It has been reported that inhibition of the PIC
nuclear import can also be prevented more specifically
by mutation in the FLAP and/or CTS region of the virus
[23,33]. We infected HeLa cells with a defective mutant,
affected in both the CTS and the PPT, and assayed
2-LTRc and 1-LTRc (relative to the WT condition) 24 h
p.i. (Figure 5C). Disruption of the FLAP structure par-
tially inhibited PIC nuclear import (and not fully as de-
scribed in [23]), and was associated with the amount of
2-LTRc being reproducibly and significantly less than for
the WT (about 2-fold). Such a decrease is compatible
with previous findings indicating that mutants affected
in the FLAP structure may replicate albeit slower than
the WT [34-36]. In this context, we found a concomitant
decrease of 1-LTRc but to a lesser extent (1.4-fold).
Taken together, these data clearly suggest that the two
mechanisms of 1-LTRc formation (and the two associ-
ated subcellular localizations) are not mutually exclusive:
1-LTRc can be formed in the cytoplasm during the re-
verse transcription step as previously suggested [30] but
that most 1-LTRc (90%) is formed by homologous re-
combination after PIC translocation in the nucleus [12].
Time course of the 3′-processing reaction in infected cells
and study of the differential stability of 3′-processed and
blunt linear viral DNAs
Regarding DNAL quantification, the ability of our PCR-
based protocol to further discriminate between both
pDNAL and uDNAL forms, prompted us to study the
kinetics of the 3′-processing reaction directly in infec-
ted cells. We used several conditions of infection: WT
(permissive for both 3′-processing and integration pro-
cesses), WT + RAL (permissive for 3′-processing reac-
tion only, according to in vitro assays [37]) or D116N
context (non permissive for both processes). At this
stage, it is important to note that our protocol for quan-
tifying total DNAL, pDNAL and uDNAL was validated
using the LTR-5′ of the virus. We performed similar
quantifications using specific primers and probes for
the LTR-3′ (see Methods). The quantification of both
Figure 5 Localization of 1-LTRc formation. (A) Left panel, HeLa cells were infected cells with NLENG1-ES-IRES D116N and fractionated into a
cytoplasmic and nuclear fraction 24 h post-infection. 2-LTRc (black columns), 1-LTRc (grey columns) and DNAL (white columns) were quantified in
each fraction. Right panel, quantification of ß-globin gene and mitochondrial gene in the nuclear and cytoplasmic compartment. (B) HeLa cells
were infected (WT + 500 nM RAL; black columns) in the presence of either 100 μM NLS-IN-Pen (dark grey columns) or 100 μM SV40-NLS-Pen
(grey columns). Percentages of 2-LTRc (left panel) and 1-LTRc (right panel) at two times post-infection are shown. (C) HeLa cells were infected
either with pNL4.3 virus (WT; black columns) or the CTS/cPPT mutant virus (grey columns). Ratios of 2-LTRc and 1-LTRc (the amount of 2-LTRc or
1-LTRc in the mutant condition divided by that for the WT at 24 h post-infection) are shown. Each value corresponds to an average of five to six
independent experiments and confidence intervals analysis are shown for a p value <0.05.
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similar values for 3′-processing activity at both LTR-3′
and LTR-5′ ends (Additional file 1: Figure S3), consistent
with a previous report [38]. In the following study, pDNAL
and uDNAL were then quantified on the LTR-5′.
Both the D116N mutation and RAL treatment prevent
integration; however, only D116N is expected to prevent
the pDNAL formation [7,39]. Indeed, RAL, like other
strand transfer inhibitors, is relatively ineffective against
the 3′-processing reaction. Accordingly, no significant
amount of pDNAL was detected with D116N (Figure 6C).
In contrast, there was no significant difference betweenthe 3′-processing activity for WT + RAL (500 nM) and
WT without RAL (Figure 6A and Figure 6B, respec-
tively). Moreover, the 3′-processing reaction was con-
comitant with reverse transcription as the maximum
amounts of both linear viral DNA (Figure 3G) and
pDNAL (Figure 6A) were found at 8 h p.i.. The reaction
yield for the 3′-processing reaction was high (more than
80% of DNAL was processed at 8 h p.i.) and corresponds
to a fast reaction as the times characterizing the max-
imum amounts of total linear viral DNA and pDNAL
coincide according to Miller’s study [40]. The pDNAL:
(pDNAL + uDNAL) ratio decreased with time after 8 h
Figure 6 Efficiency of the 3′-processing reaction during a single round of replication. MT4 cells were infected with the VSV-G-pseudotyped
NLENG1-ES-IRES WT (+/- RAL 500 nM) or NLENG1-ES-IRES D116N viruses. (A) WT; (B) WT + 500 nM RAL; (C) D116N: unprocessed linear DNA
(uDNAL, white circles); 3′-processed linear DNA (pDNAL, black squares). (D) Percentage of pDNAL (pDNAL over DNAL) during the time course of
infection (WT: black columns, WT + 500 nM RAL: grey columns, D116N: white columns). Each value corresponds to an average of five to six
independent experiments and confidence intervals analysis are shown for a p value <0.05.
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ing that pDNAL was less stable than uDNAL (Figure 6D).
For each time point along the decreasing phase, this ra-
tio was consistently lower in the absence of RAL than
presence of RAL. Such a difference most likely accounts
for integration events that occur in the absence of RAL.
Differential inhibition of the 3′-processing reaction by
RAL, EVG and DTG
Two other strand-transfer inhibitors, DTG and EVG
[41,42], were studied for their ability to inhibit the 3′-
processing reaction and were systematically compared to
RAL. The three drugs display similar IC50 for the in-
tegration inhibition during viral infection: 2 nM for
DTG and EVG and 8 nM for RAL (Additional file 1:
Figure S4A). Quantitative PCR was used to assay pDNAL
and uDNAL as described above. At the lowest concen-
tration (500 nM) of RAL, DTG or EVG, which fully in-
hibits viral integration, the 3′-processing step was not
significantly impaired (Figure 7A, upper panel). Interest-
ingly, the three drugs at higher concentrations had dif-
ferent effects on the 3′-processing reaction (Figure 7B-C,
upper panels). Indeed, RAL at concentrations up to 5 μM
did not effectively inhibit 3′-processing (3′-processing ef-
ficiency was still 80% at 5 μM RAL). By contrast, 3′-pro-
cessing was greatly impaired using 2.5 or 5 μM of DTG
and EVG (3′-processing efficiencies were about 40% andbelow 25% at 2.5 μM and 5 μM, respectively). Accor-
dingly, in vitro studies, using recombinant integrase, dem-
onstrate that the three integrase inhibitors do not inhibit
the 3′-processing reaction to the same extent (Additional
file 1: Figure S4B). IC50 values for 3′-processing inhibition
were 2 μM, 5 μM and 10 μM for DTG, EVG and RAL, re-
spectively according to Metifiot et al. study for RAL and
EVG [43]. The differential effects of the three compounds
on the 3′-processing reaction were confirmed using a
radiolabeled probe produced by PCR (as described in the
online methods section) (Additional file 1: Figure S4C). As
shown in Figure 7, the presence of 500 nM of any of RAL,
DTG and EVG led to similar amounts of 3′-processed
DNA whereas, at 5 μM, DTG and EVG significantly
inhibited 3′-processing, in contrast to that observed
for RAL.
Interestingly, increasing the DTG or EVG concentra-
tion, from 500 nM to 5 μM, progressively increased the
inhibition of 3′-processing but did not lead to a greater
accumulation of 2-LTRc (Figure 7A-C, middle and lower
panels). Indeed, across this concentration range where
DTG and EVG equally (and fully) inhibit integration
while 3′-processing inhibition is concentration depen-
dent. 2-LTRc consistently represent nearly 40% of the
total viral DNA 48 h p.i.. Such a comparable global ac-
cumulation of 2-LTRc, regardless of the 3′-processing
efficiency, could be explained as above-mentioned by a
Figure 7 Strand-transfer inhibitors have different effects on the 3′-processing reaction. MT4 cells were infected with VSV-G-pseudotyped
NLENG1-ES-IRES WT virus in the absence or in the presence of increasing concentration of strand-transfer inhibitors (RAL, DTG or EVG): 500 nM
(A), 2.5 μM (B) or 5 μM (C). Viral DNA was analyzed 15 h and 24 h post-infection. The percentage of the 3′-processed DNA was normalized to the
value obtained in the WT condition (upper panels). WT: white columns; RAL: black columns; DTG: dark grey squares; EVG: grey columns.
Percentages of 2-LTRc and 1-LTRc are shown in middle panels and bottom panels, respectively. Each value corresponds to an average of five to
six independent experiments and confidence intervals analysis are shown for a p value <0.05.
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fect junction which is modulated by the 3′-processing
efficiency (see Figure 4). All together, our data show that,
at submicromolar concentration, INSTIs behave simi-
larly in the virological context and in vitro (i.e. they are
specific inhibitors of the strand-transfer reaction and
have little effect on the 3′-processing reaction), and that
the 3′-processing reaction influences the nature of
2-LTRc qualitatively but not quantitatively. We also
measured 3′-processing efficiency during infection of
primary CD4 + T cells with the previously described vi-
ruses Δenv WT (+/- 5 μM RAL, EVG or DTG). As de-
scribed previously during MT4 infection, 3′-processing
reaction efficiency was high (75%) but slightly delayed in
primary cells (3′-processing reaction peaked 24 h p.i.)
and was influenced by 5 μM EVG and DTG but not
RAL, as previously found in MT4 cells (Additional file 1:
Figure S5). Furthermore, the kinetics of 2-LTRc and
1-LTRc were similar in primary cells and in MT4 in-
fections (Additional file 1: Figure S5, middle and right
panels).Discussion
Methods are available to quantify accurately various
HIV-1 viral DNA forms including total viral DNA, 2-
LTRc and integrated viral DNA [18]. However, no me-
thodology had been developed for assaying 1-LTRc in a
sensitive manner. It has even been suggested that PCR-
based methods are unable to quantify 1-LTRc [20].
Amplification with primers spanning the LTR leads to
unspecific amplification from both DNAL and 2-LTRc.
The appropriate application of one crucial parameter
(elongation time) explains why our methodology is ac-
curate for 1-LTRc quantification. We found empirically
that an elongation time of 25 s was optimal for efficient
and specific amplification of 1-LTRc. A shorter elong-
ation time (18 s) was associated with a lower amplifica-
tion efficiency whereas a longer elongation time (32 s)
resulted in unspecific amplification from DNA mimic-
king DNAL (Additional file 1: Figure S2). For example,
amplification of 200,000 copies of DNAL (as quanti-
fied by primers and probes used for total viral DNA
quantification) using our 1-LTRc protocol, but with
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ies corresponding to 43% of unspecific amplification
(Additional file 1: Figure S2, right table). Our results,
sustained by those obtained by Yoder and colleagues,
indicate that increasing elongation time leads to un-
specific amplification and particularly from DNAL.
The elongation time used by Yoder and colleagues
was even longer (60s), and not compatible with a reli-
able quantification of 1-LTRc [20]. Concerning DNAL,
the number of cycles in the first PCR (12 cycles) was
determinant for reliable quantification. We compared
the sensitivity of our method to that of Southern
blotting: the sensitivity of our quantitative PCR was
102 copies/106 cells, whereas that of Southern blotting
was 105 copies/106 cells.
We used these methods to determine the amounts of
1-LTRc and DNAL in its two forms (3′-processed DNA
(pDNAL) or unprocessed (uDNAL)) in several conditions
of infections. The findings of these analyses contribute
to understanding various unresolved issues (i) the pre-
cise timing, efficiency and localization of the processing
step required for the proper integration of viral DNA (ii)
the relative lifetimes of DNAL and circular viral forms
(iii) the mechanism of action of anti-integrase com-
pounds during infection (i.e. inhibitors of 3′-processing
only, inhibitors of strand-transfer only or inhibitors of
both reactions) and (iv) the localization of the formation
of circular viral DNA forms.
Characterization of linear viral DNA forms
Regarding the quantification of DNAL, our quantitative
PCR-based methodology allows to discriminate between
uDNAL and pDNAL. We showed that the 3′-processing
reaction corresponds to an early event that is concomi-
tant with the reverse transcription step, evidence that
3′-processing occurs in the cytoplasmic compartment.
In both MT4 cell line and primary CD4 + T cells, 85% of
the DNAL is 3′-processed (Figure 6D) indicating that 3′-
processing in the wild-type context is efficient. Given
this high reaction efficiency, it is unlikely that 3′-pro-
cessing is the limiting factor for integration (40% of the
total viral DNA is integrated (Figure 3B)). The relatively
low integration yield may be a consequence of the for-
mation of circular forms, poor stability of pDNAL (see
below) or inefficiency of the strand transfer reaction.
We found the following order for the stability of
the viral DNA forms: integrated DNA > circular DNA
(1-LTRc and 2-LTRc) > uDNAL > pDNAL. Integrated
DNA is the most stable form due to its replication
with cellular DNA, whereas circular forms are diluted
by cell division. The loss of DNAL is believed to be
the consequence of several phenomena: integration of
pDNAL, degradation of viral extremities by cellular pro-
teins and circularization of DNAL [44-46]. Additionally,we found that the lifetime of pDNAL was shorter com-
pared to uDNAL and therefore that pDNAL is intrinsically
less stable than uDNAL. Indeed, in the absence of RAL,
pDNAL is integrated into the host cell genome, explai-
ning, at least in part, its disappearance. However, even
in the presence of RAL such that no pDNAL is inte-
grated, pDNAL remains less stable than uDNAL. The
relative instability of pDNAL in this condition is prob-
ably due to a conformational modification of IN after
3′-processing resulting in a lower stability of IN itself
on the viral DNA end. In the absence of any integra-
tion event, IN can dissociate from the LTR ends leading
to degradation of the LTR ends.
Nanomolar concentrations of RAL, DTG and EVG
efficiently inhibit the integration process [47,48]. We
found that, although RAL, DTG and EVG in the micro-
molar range inhibit 3′-processing to different extents
both in vitro and in the virological context, none of
these compounds inhibit 3′-processing in infected cells
at submicromolar concentrations that fully inhibit inte-
gration (e.g. 500 nM). This demonstrates that RAL, DTG
and EVG are primarily INSTI compounds in the viro-
logical context. As uDNAL is more stable than pDNAL,
it is important to know the performance of anti-IN in-
hibitors, with clinical potential, against 3′-processing in
the virological context. Indeed, compounds which, in
the same concentration range, inhibit both integration
and 3′-processing reactions, may favor accumulation
of uDNAL relative to pDNAL (due to 3′-processing
inhibition). Due to the greater stability of uDNAL,
this could be a risk factor for viral resumption.
Formation of circular viral DNA forms
It has been clearly demonstrated that 2-LTRc are formed
in the nucleus of infected cells [49], and we confirmed
this result (Figure 5). The situation is less clear for
1-LTRc. Indeed, a significant amount of 1-LTRc (10% of
total 1-LTRc) was detected in the cytoplasmic fraction,
consistent with 1-LTRc formation being linked to re-
verse transcription as early suggested by Miller and col-
leagues [30]. However, we found that 90% of the 1-LTRc
was in the nuclear compartment, and that the total
mount of 1-LTRc was reduced when nuclear import was
impaired (using peptides inhibiting the integrase-
importinα or a PPT/CTS mutant). Therefore, most of 1-
LTRc are generated in the nucleus. Thus, our results
reconciles apparent contradictions in the literature and
indicate that there are two mechanisms of 1-LTRc
formation co-exist in infected cells, whereas 2-LTRc
are exclusively formed in the nucleus.
We also observed that the overall amount of 2-LTRc
accumulation (including both of 2-LTRc: the first sub-
group encompassing a perfect palindromic junction and
the second harboring an imperfect palindromic junction)
Munir et al. Retrovirology 2013, 10:87 Page 12 of 18
http://www.retrovirology.com/content/10/1/87was not directly related to the 3′-processing reaction: in-
creasing EVG or DTG concentrations from 500 nM to
5 μM, and thereby modulating the 3′-processing reac-
tion yield, did not affect the 2-LTRc accumulation. This
confirms previous studies reporting that amount of
2-LTRc was the same after RAL treatment (believed not
to inhibit 3′-processing) or infection with the D116N
mutant (3′-processing is inhibited) [29,50]. This result is
somewhat surprising since, due to the incompatibility of
the 3′-processed ends with circularization of DNAL, the
amount of 2-LTRc would be expected to be impaired.
However, we found that 500 nM RAL did not inhibit 3′-
processing in the virological context or in vitro, and that
RAL treatment and D116N did not led to accumulation
of the two 2-LTRc subgroups to the same extent. Fol-
lowing RAL treatment, about 50% of 2-LTRc have a per-
fect palindromic junction, as in the case in control WT
conditions, whereas in the D116N condition 80% of the
2-LTRc have a perfect palindromic junction (Figure 4).
In conclusion, 3′-processing efficiency does not influ-
ence the total amount of 2-LTRc but affects the nature
of the palindromic junction in the 2-LTRc (perfect ver-
sus imperfect junctions).
Conclusions
Our methods allowing accurate quantification of 1-LTRc
and DNAL have provided important information about
the fate of the various viral DNA forms (integrated viral
DNA, 2-LTRc, 1-LTRc and DNAL) during viral infection
and could be applied to study the lifetime of circular and
linear DNA in patients. Other viral DNA forms origina-
ting from auto-integration exist. As underlined by Yan
et al., it is a hard task to quantify these viral DNA forms
due to their heterogeneous nature [15]. However, these
forms appear to be not highly represented relative to the
total viral DNA. Indeed, our data show that the amount
of total viral DNA is similar to the addition of inte-
grated, 1-LTRc, 2-LTRc and DNAL amounts. These
methods can be used to follow the fate of viral DNA
forms, the distributions of which may be influenced by
mutations or inhibitors of HIV-1 viral proteins. Indeed,
the quantification of 3′-processed DNA in infected cells
may help to elucidate, directly in the cell context, the




MT4 and Nalm6/Nalm114 cells were cultured in
RPMI1640. The ligase 4 gene was knockout from the
parental cell line Nalm-6 to obtain Nalm-114 cells. Lig-
ase 4 is a component of the NHEJ (Non-Homologous
End Joining) pathway involved in 2-LTRc formation [12].
HeLa and 293 T cells were cultured in DMEM. Bothmediums were supplemented with 10% fetal calf serum.
HIV-1 pNL4.3 stocks were prepared by transfecting
293 T with the HIV-1 molecular clone pNL4.3 or with
HIV-1 molecular clones derived from the pNL4-3 (Δenv
viruses) [26]. Δenv viruses NLENG1-ES-IRES WT and
NLENG1-ES-IRES D116N encode the WT and catalytic-
ally inactive mutant D116N, respectively. Pseudotyping
of Δenv viruses was performed by co-transfection of
293 T cells with a VSV-G plasmid using the calcium phos-
phate method. Viral supernatants were filtered (0.45 μm)
and frozen at −80°C.
Isolation of highly purified CD4 + T cells
Highly purified CD4 + T cells were isolated from periph-
eral blood mononuclear cells (PBMC) of HIV-1 negative
donors from EFS (Etablissement Français du Sang).
Briefly, PBMC were obtained by centrifugation on Ficoll-
Hypaque gradient. Purification of CD4 + T cells was
achieved by staining cells with CD4 MicroBeads (MACS®,
Miltenyi Biotec) and purified with the Whole Blood Col-
umn Kit (MACS®, Miltenyi Biotec). Purified CD4 + T cells
were cultured in RPMI1640 supplemented with 2%
Human serum, penicillin-streptomicine, and in pres-
ence of IL-2 (50 ng/ml). CD4 + T cells were activated
with phytohemagglutinin (PHA, 2.5 μg/ml) during
3 days and were used for experiments 7 days after
the activation treatment.
Viral infection
HIV-1 p24gag antigen contents in viral inocula were
determined by enzyme-linked immunosorbent assay
(Perkin-Elmer Life Sciences). For the WT, 120 ng of
p24gag antigen per 106 cells, corresponding to a multipli-
city of infection (m.o.i.) of 0.3, was used for infection.
Primary CD4 + T cells were infected with 100 ng of
p24gag antigen per 106 cells. When required, cells were
treated in the presence of several integrase inhibitors
such as RAL, DTG and EVG at 500 nM, 2.5 μM or
5 μM. Two to five millions cells were collected at each
time point. Cells were washed in PBS, and dry cell pel-
lets were frozen at -80°C until use. DNA from infected
cells was purified with QIAamp DNA Blood mini kit
(Qiagen) according to the manufacturer’s instructions.
To digest residual transfection plasmid, DNA was incu-
bated with 10 units of DpnI (NEB) according to the
manufacturer’s instructions for 4 hours at 37°C.
Plasmids
Four plasmids were constructed for standard curves am-
plification: p1-LTR, p2-LTR, pLIN-HIV-ScaI and pLIN-
HIV-NdeI.
pLIN-HIV-ScaI plasmid was constructed using a linker-
mediated PCR (LM-PCR). MT4 cells were infected with
pNL4.3 HIV-1 and DNA was extracted. The three terminal
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the ScaI restriction site. Viral DNA was ligated with a
linker composed of oligonucleotides 25SCAt (5′-GC
GGTGACCCGGGAGATCTGAATTCAGT-3′) and 11SCAb
(5′-ACTGAATTCAGATCTCCCGG-3′), containing the
complementary moiety of ScaI site. The ligation product
was next used to amplify the termini of linear viral
genome linked with the linker by PCR using primers
25 t and MS1 (see Additional file 1: Table S1B). PCR
was performed as follows: 95°C/30 sec, 55°C/30 sec
and 68°C/1mn for 35 cycles. The reaction product
was purified on agarose gel, cloned into the pGEM-T
easy vectors (Promega) and sequenced. Note that the
ScaI site in the pGEM-T easy vector was removed by
site directed mutagenesis (QuikChange Lightning Kits,
Agilent). Site directed mutagenesis (QuikChange Light-
ning Kits, Agilent) was also performed on this plasmid to
remove the ScaI recognition site in position 314 in the
LTR5′ with primers 5′-CCCGAGAGCTGCATCCGGA
GAACTACAAAGACTGCTGACATCG-3′ and 5′-CGA
TGTCAGCAGTCTTTGTAGTTCTCCGGATGCAGCTC
TCGGG-3′. The final plasmid, pLIN-HIV-ScaI, contains
only one ScaI site at the bounder of the linker and LTR5′
extremity. Digestion with ScaI and AatII leads to a frag-
ment mimicking the extremity (LTR5′) of unprocessed
viral DNA end. After purification, this fragment was used
for ligation reaction with linker 11b in order to quantify
unprocessed linear DNA (uDNAL).
pLIN-HIV-NdeI was constructed by site directed mu-
tagenesis (QuikChange Lightning Kits, Agilent) to re-
place the ScaI site by NdeI site at the linker-viral DNA
junction, using primers 5′-CCGGGAGATCTGAATTC
AGTCATATGGAAGGGCTAATTTGGTCC-3′ and 5′-
GGACCAAA TTAGCCCTTCCATATGACTGAATTCA
GATCTCCCGG-3′. The digestion with NdeI and AatII
leads to a fragment mimicking the extremity of the 3′-
processed viral DNA. After purification, this fragment
was used for ligation reaction with linker 11TAb.
p1-LTR was obtained by amplification, from HIV-1
infected cells DNA, of the env-LTR-gag region, specific-
ally present on 1-LTRc, using primers 1LTR LA1 and
1LTR LA16 (see Additional file 1: Table S1B). This amp-
lification product was cloned into the pGEMT-easy vec-
tor (Promega) to give p1-LTR.
p2-LTR was constructed in two steps as follows: pLIN-
HIV-ScaI-LTR3′ was first constructed by the same me-
thodology described for pLIN-HIV-ScaI. Primers used
for LM-PCR were 25 t and 1LTR LA16 (see Additional
file 1: Table S1B), resulting in amplification of the env-
LTR3′ region. The ScaI recognition site present in the
LTR3′ of pLIN-HIV-ScaI-LTR3′ was mutated (as previ-
ously done for the ScaI site in the LTR5′ of pLIN-HIV-
ScaI) by site directed mutagenesis (QuikChange Lightning
Kits, Agilent) using primers 5′-AGCTGCATCCGGAGCACTTCAAGAACTGCT-3′ and 5′-AGCAGTTCTTGAA
GTGCTCCGGATGCAGCT-3′. The two plasmids, pLIN-
HIV-ScaI and pLIN-HIV-ScaI-LTR3′, were digested by
ScaI, and fragments containing respectively the env-LTR3′
and the gag-LTR5′ regions were purified on agarose
gel and ligated together into the pGEMT-easy vector
(Promega) to give p-2LTR.
Quantification of total linear DNA (DNAL), unprocessed
(uDNAL) and 3′-processed (pDNAL) linear forms by LM-PCR
Principle
DNAL quantification was performed by a linker-me-
diated PCR approach (LM-PCR). The choice of the
linkers was based on the early study by Pierson and col-
leagues [22]. In order to quantify either the total amount
of linear DNA (DNAL) -which comprises both the un-
processed (uDNAL) and the 3′-processed (pDNAL)- or,
more specifically, the uDNAL only, we used the linkers
11TAb and 11b, respectively, for establishing standard
calibration (Additional file 1: Table S1A). Two rounds of
PCR were performed using primers and probes de-
scribed in Additional file 1: Table S1B; the number of
rounds of the first PCR was critical for further quantita-
tive analysis and we found that 12 cycles correspond to
the optimal condition for the two linkers (Additional
file 1: Figure S6).
Method
Quantifications were performed by real-time PCR on a
Light cycler instrument (Roche Diagnostics) using the
second-derivative-maximum method provided by the
Light Cycler quantification software, version 3.5 (Roche
Diagnostics). Two linkers: Linker 11b and 11TAb (or
11GTb in the virological context; see below) (see
Additional file 1: Table S1A) were used for the quantifi-
cation of uDNAL and pDNAL, respectively. These linkers
were assembled by annealing two partially complemen-
tary unphosphorylated oligonucleotides (to give 34 nM)
final concentration) in the presence of 200 mM NaCl.
To quantify linear forms of HIV-1 DNA, a ligation reac-
tion mixture was carried out by addition of linkers (final
concentration: 30 nM) to DNA, in the presence of 10
units of ligase from the Quick ligation kit (NEB), for
2 hours at room temperature in a final volume of 20 μL,
according to the manufacturer’s instructions. Linked
DNA products were then purified with PCR switch
charge purification kits (Life Technology) according to
the manufacturer’s instructions (to prevent inhibition of
the PCR due to the mixture of ligation reaction) and
eluted in 20 μL and then submitted to real-time PCR.
In a first round of PCR, 1/10 of DNA was amplified
in duplicate in a 20 μl reaction mixture comprising 1 ×
LightCycler FastStart DNA master Hybprobes (Roche),
4 mM MgCl2, 32 t and MS1 primers (300nM) for
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or 32 t and 1LTR LA15 (5′- CACACCTCAGGTA
CCTTTAAGA-3′) (300 nM) for LTR3′. To remain in the
exponential phase allowing quantitative properties of the
second PCR, 12 cycles are required for the first PCR.
Decreasing the number of cycles for the first PCR leads
a non-reproducibility in the samples quantifications
(Additional file 1: Figure S6). Increasing the number of
cycles for the first PCR results in a false quantification be-
cause the exponential phase allowing quantitative proper-
ties of the second PCR is not respected (Additional file 1:
Figure S6). 12 cycles are sufficient to ensure quantitative
conditions for all linked-DNA dilutions for the second
PCR. The second PCR was performed on 1/100 of the first
PCR-product in a mixture comprising 1 × LightCycler
FastStart DNA master Hybprobes, 4 mM MgCl2, 25 t and
MS2 primers (300 nM) and hybridization probes MH FL
and MH LC (200 nM) for quantification of the LTR5′
(Additional file 1: Table S1B) or 25 t and 1LTRnested
(5′- GCTAATTCACTCCCAACGAAG-3′) (300 nM) and
hybridization probes LTR FL and LTR LC (200 nM)
(Additional file 1: Table S1B) for LTR3′. Efficiency of the
uDNAL quantification was determined by addition of the
linker 11b to serial dilutions of the fragment from the
digestion of pLIN-HIV-ScaI with ScaI and AatII. For
pDNAL quantification, the efficiency of the procedure was
determined by addition of the linker 11TAb (composed of
oligonucleotides 25 t and 11TAb) (see Additional file 1:
Table S1A) to serial dilutions of the fragment obtained
after digestion of pLIN-HIV-NdeI with NdeI and AatII.
11GTb characterization as well as comparison bet-
ween Southern blot and quantitative PCR were shown
in Additional file 1: Figure S1).
Method validation
To assess both the sensitivity and the linear range of
amplification, we used DNA mimicking the uDNAL or
pDNAL (obtained by ScaI/AatII or NdeI/AatII diges-
tion of pLIN-HIV-ScaI or pLIN-HIV-NdeI, respectively
(Figure 1A)). uDNAL or pDNAL were quantified inde-
pendently using total viral DNA quantification protocol
(line 1, Additional file 1: Table S1B). The standard curves
were monitored by serial dilutions of the fragments
mimicking uDNAL or pDNAL in DNA of uninfected
cells. Linkers 11TAb or 11b were used for ligation of
each dilutions of viral DNA extremity (uDNAL or
pDNAL). After ligation and DNA purification, 1/10 of
the ligation reaction was submitted to real-time PCR
(12 cycles as above-mentioned). It is important to note
that quantifications of samples account for the ligation
efficiency. Amplified products were diluted (1/10) and
next submitted to the second PCR round. Efficiencies and
sensitivities related to uDNAL and pDNAL quantifica-
tion were identical (90% efficiency on a 7-log range;sensitivity of 10 copies for 200,000 cells) (Figure 1B). To
assess the specificity of the quantification procedure, we
tested the detection efficiency of pDNAL or uDNAL
when using either 11TAb or 11b linker (Figure 1C). We
confirmed qualitative results from Pierson [22], i.e. 11TAb
was not able to discriminate between pDNAL and uDNAL,
while 11b led to detection of uDNAL only. From a quanti-
tative point of view, the detection efficiency of pDNAL
and uDNAL by LM-PCR using 11TAb as a linker was
identical and high (90%) (Figures 1B and Figure 1C).
The LM-PCR with linker 11b allows a high degree of
selectivity in the detection, with detection efficiencies
of 95% and 3% for uDNAL and pDNAL, respectively
(Figure 1C). Performing two independent experiments
(each one with a different linker), accurate quantifica-
tions of the total amount of DNAL and the amount
of uDNAL are thus possible. The pDNAL amount can
be then simply deduced by subtraction: total DNAL
(using 11TAb) minus uDNAL (using 11b). The ability
of the linker 11TAb to detect uDNAL could be due
to the fact that the overhanging nucleotides of the
linker (AT-5′; complementary to the overhanging 5′-
TA of pDNAL) are not involved in ligation with the
phosphate at the 5′-DNAL end, leading to equivalent
detection of uDNAL and pDNAL.
Analysis of the time course of 3′-processing reaction in
infected cells
For quantification of pDNAL in infected cells, the linker
11TAb was replaced by the linker 11GTb (the above men-
tioned linker 11b is still used for uDNAL quantification in
infected cells). Ligations for the different standard curves
were performed in uninfected cells DNA (200 ng/μl) in
order to check that the ligation/amplification efficiency
was not influenced by the trapping of linker by uninfected
DNA. The copy number of linear DNA was determined in
reference to a standard curve prepared by amplification of
quantities ranging from 10 to 105 copies of corresponding
digested fragments. PCR parameters for all PCR protocols
are given in Additional file 1: Table S1B. We demonstrated
that the 11GTb linker is able to detect the uDNAL and
the pDNAL with a similar efficiency (90%) (Figure 1B),
whereas the linker 11b can only detect uDNAL. These two
parameters have been taking into account for the calcu-
lation of pDNAL amount. Formula given the amounts of
unprocessed DNAL (uDNAL) and 3′-processed DNAL
(pDNAL) are described below:
uDNAL = amount found with the linker 11b,
pDNAL = amount found with the linker 11GTb -
amount found with the linker 11b;
If no processing occurs (see below) the values obtained
with linkers 11b and 11GTb are identical.
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Principle
One problem of 1-LTRc quantification is that primers
hybridizing in the env and gag genes could lead to amp-
lification of the LTR-LTR region present in 2-LTRc and
amplification of DNAL via LTR recombination (see
Figure 2A). In the method described below, we estab-
lished PCR condition (mainly the elongation time of the
PCR) which leads to specific detection of 1-LTRc.
Method and validation
For 1-LTRc quantification, reaction mixture contained
1 × LightCycler FastStart DNA master Hybprobes (Roche
Diagnostics), 4 mM MgCl2, 300 nM of primers, and hy-
bridization probes (200 nM each), in a final volume of
20 μl. PCR cycle conditions are shown in Additional file 1:
Table S1B. Optimal elongation time for further quantita-
tive analysis was found to be 25 s. Amplification using
1LTR LA1 and 1LTR LA16 (Additional file 1: Table S1B)
was performed with p1-LTR (Figure 2B) used as a stan-
dard curve. p2-LTR (Figure 2B) which contains two full-
length LTRs flanked by the gag and env genes was used as
a control. Quantitative PCR using p1-LTR led to high
amplification (92.5-100%) and sensitive detection (200
copies/106 cells) of 1-LTRc (Figure 2 C1). Under the same
condition, p2-LTR led to weak amplification (0.7-2%),
regardless of the initial amount used (Figure 2 C2).
Next, p2-LTR was digested using ScaI to mimic DNAL
(Figure 2B). As found for p2-LTR, DNAL amplifications
was found to be negligible (<0.1%) (Figure 2 C3). Taken
together, our results show that our protocol is compatible
with an accurate 1-LTRc quantification and overcomes
the bias due to DNAL and/or 2-LTRc amplification.
Quantifications of 2-LTR circles harboring perfect or
imperfect LTR-LTR junction, total HIV-1 DNA, integrated
viral DNA, ß-globin gene and mitochondrial 12S gene.
These real-time PCR quantifications were based on
well established protocols. Sequences of primers and
probes for 2-LTR circles, total HIV-1 DNA and integra-
ted viral DNA are given in Additional file 1: Table S1B.
Briefly, for 2-LTRc and total viral DNA quantifications,
reaction mixtures contained 1 × LightCycler FastStart DNA
master Hybprobes (Roche Diagnostics), 4 mM MgCl2,
300 nM of primers, and hybridization probes (200 nM
each), in a final volume of 20 μl. PCR cycle conditions are
shown in Additional file 1: Table S1B. Copy numbers
of the different forms of viral DNA were determined
in reference to a standard curve prepared by serial dilu-
tions of the corresponding plasmid: p2-LTR and pNL4.3
for 2-LTRc and total viral DNA quantifications, respect-
ively. Quantification of 2-LTRc harboring a perfect LTR-
LTR junction has been achieved according to De Iaco and
colleagues [11]. Briefly, 2-LTRc harboring a perfect LTR-
LTR junction were quantified using HIV-R1: 5′-ACTGGTACTAGCTTGTAGCACCATCCA-3′, a primer overlap-
ping the perfect 2-LTRc junction Junct4-fwd: 5′- CAG
TGTGGAAAATCTCTAGCAGTACTG-3′ and two fluo-
rogenic hybridization probes HIV-FL: 5′-CCACACA
CAAGGCTACTTCCCTGA-3′ and HIV-LC: 5′-TG
GCAGAACTACACACCAGGGC-3′. Reaction mixtures
contained 1 × Light Cycler Fast Start DNA master hy-
bridization probes (Roche Diagnostics), 4 mM MgCl2,
300 nM forward and reverse primers, and 200 nM (each)
fluorogenic hybridization probe, in a final volume of 20 μl.
PCR cycle conditions for conventional and perfect two-
LTR circles HIV-1 DNA amplifications were (dena-
turation: 95°C, 8 min; PCR cycles: 95°C, 10 s, 60°C, 10 s,
72°C, 6 s for 50 cycles). Quantification of integrated viral
DNA was performed as described previously [29]. Human
ß-globin gene was quantified with commercially available
materials (Control kit DNA; Roche Diagnostics). The
mitochondrial 12S gene was quantified using the protocol
developed by Petit and colleagues [51].
3′-processing of U5 extremity with radiolabeled probes
MT4 (5.106 cells) were infected with VSV-G-pseu-
dotyped NLENG1-ES-IRES D116N or NLENG1-ES-
IRES WT +/- RAL, DTG or EVG (500 nM or 5 μM).
10 h post-infection, DNA was extracted from the cyto-
plasmic compartment and digested with HindIII. The
digested DNA was fractionated through DNA sequen-
cing gels. After electrophoresis, DNA was transferred on
a Hybond-N +membrane (Amersham) according to
manufacturer’s instructions. For detection of both un-
processed and processed U5 extremity, a PCR fragment
was produced with 5′-GTGCCCGTCTGTTGTGTG
ACT-3′ and 5′-ACTGGTACTAGCTTGTAGCACCA
TCCA-3′ primers in the presence of α-CTP32. After
purification, this PCR probe was heated (95°C, 5 min)
and used for hydridization of the membrane according
to the manufacturer’s instructions. Then, the membrane
was washed and processed for autoradiography. Southern
blot in Figure S1A has been performed with DNA from
MT4 cells infected with NLENG1-ES-IRES D116N.
Briefly, DNA was extracted, digested with SpeI, purified
and quantified using the LM-PCR and total viral DNA
protocols. DNA was loaded on a 1% agarose gel and de-
tection was performed using the PCR probe described
above.
Cell fractionation
5.106 cells were infected with VSV-G-pseudotyped
NLENG1-ES-IRES D116N. 24 h post infection, cells
were harvested, washed with PBS and the pellet was
resuspended in 0.5 mL of isotonic buffer 1 (20 mM
HEPES pH 7.4, 110 mM KCl, 5 mM MgCl2, 0.5 mM
EGTA, 1 mM DTT, 20 μg/ml aprotinin, 20 μg/ml
leupeptin). Samples were centrifuged for 2 min at 420 g
Munir et al. Retrovirology 2013, 10:87 Page 16 of 18
http://www.retrovirology.com/content/10/1/87(4°C); the pellet was gently resuspended on ice in 50 μl
of isotonic buffer 1, then 0.5 ml isotonic buffer + 0,005%
digitonine was added and samples were incubated for
5 min on ice. Following a 2 min centrifugation (420 g at
4°C), the supernatant was cleared by centrifugation at
8,600 g (20 min at 4°C). The supernatant constitutes the
cytoplasmic compartment. The pellet was washed in
0.5 ml of isotonic buffer 1 once, resuspended in 1 ml of
isotonic buffer 2 (50 mM TrisHCl pH 7.5, 25 mM KCl,
5 mM MgCl2, 0.25 M sucrose) mixed with 2 ml of iso-
tonic buffer 2 + 2.3 M sucrose and placed in a 5 ml ul-
tracentrifuge tube on ice. Samples were then underlayed
with 1 ml of isotonic buffer 2 + 2.3 M sucrose and
centrifuged at 88,000 g in a SW55 TI rotor at 4°C for
40 min. The interface containing purified nuclei was col-
lected. Nuclei and cytoplasmic extracts were mixed with
1 volume of 2 × lysis buffer (100 mM Tris-HCl pH 8, 1%
SDS, 10 mM EDTA, 50 μg/ml proteinase K), incubated
for 4 hours at 55°C; nucleic acids were isolated by phe-
nol/chloroform and ethanol precipitation.
Peptides
Peptides used in this study (NLS-IN-Pen and SV40-NLS-
Pen) were previously described to inhibit HIV-1 integrase
nuclear import [32]. They were purchased from GeneCust
at >95% purity. HeLa cells were growth, arrested with
5 μg/ml of aphidicholine and then incubated with 100 μM
of peptide for 6 h. Cells were then infected as above de-
scribed. Viral DNA molecules were then analyzed by
quantitative PCR.
Mutant CTS/PPT
The viral molecular clone, kindly provided by Dr Nathalie
Arhel, used in this study is described to be impaired in the
nuclear import (cPPT and CTS double mutant) due to the
disruption of the FLAP structure [23].
Characterization of integrase enzymatic activity in vitro
Recombinant Integrase was produced in Escherichia coli
BL21-CodonPlus (DE3)RIPL (Agilent, Santa Clara, USA)
and purified under non-denaturing conditions, as previ-
ously described [52]. Oligonucleotide (ODN) mimicking
the U5 LTR end of the viral genome (U5B) was radio-
labeled with T4 polynucleotide kinase (Biolabs, Ipswich,
USA) and [γ-32P] ATP (Amersham, GE Healthcare, USA),
then purified on a Sephadex G-10 column. Double-
stranded ODN was obtained by mixing equimolar amount
of complementary strand in the presence of 100 mM
NaCl. 3′-processing assay was carried out at 37°C in a
buffer containing 20 mM HEPES (pH 6.8), 1 mM di-
thiothreitol (DTT), 7.5 mM MgCl2 and 50 mM NaCl in
the presence of a 6.25 nM U5A/U5B double-stranded
DNA substrate. Products were separated by in a 16%
acrylamide/urea denaturing gel, analyzed with a TyphoonTRIO variable mode imager (GE Healthcare, USA) and
quantified with ImageQuant TL software. The susceptibil-
ity of IN to RAL, EVG and DTG was determined in vitro
by assessing IN activity in the presence of various con-
centrations of strand transfer inhibitors. 50% inhibitory
concentrations (IC50) were determined with Prism 5.0
software. The HIV-1 ODN substrate sequences were:
U5B: 5′-GTGTGGAAAATCTCTAGCAGT-3′; U5A: 5′-
ACTGCTAGAGATTTTCCACAC-3′.Additional file
Additional file 1: The data sets supporting the results of this article
are available: Table S1, Figures S1-S6.
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